Figure 4 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
Elisa Izquierdo(Institute of Cancer Research), Chris Jones(North Carolina State University), Susan Picton(Helios Klinikum Emil von Behring), Georgia Roumelioti(Institute of Cancer Research), Paula Proszek(BMW (Germany)), Darren Hargrave(Great Ormond Street Hospital), Yura Grabovska(Newcastle University), Jyoti S. Choudhary(Institute of Cancer Research), Amy R. Fairchild(Great Ormond Street Hospital), Sarita Depani(Great Ormond Street Hospital for Children NHS Foundation Trust), Fernando Carceller, Bassel Zebian(King's College London), Juliet C. Gray(University of Southampton), Michael Hubank(Royal Marsden Hospital), Valeria Molinari(Institute of Cancer Research), Shaun K. Wilson(Australian Institute of Marine Science), Lisa Howell(Alder Hey Children's NHS Foundation Trust), Jacques Grill(Institut Gustave Roussy), Sara Temelso(Institute of Cancer Research), Giulia Pericoli(Bambino Gesù Children's Hospital), Matthew Clarke(University of Aberdeen), Richard G. Grundy(Brain Tumour Research), Jenny Adamski(Birmingham Women's Hospital), Molina Das(Institute of Cancer Research), Thomas S. Jacques(Great Ormond Street Hospital), Maria Antonietta Ajmone‐Cat(Istituto Superiore di Sanità), Alan Mackay(Institute of Cancer Research), Diana Carvalho(Institute of Cancer Research), Rebecca F. Rogers(Institute of Cancer Research), Lu Yu(Hubei University of Medicine), Mark Stubbs(Institute of Cancer Research), Lynley V. Marshall(Royal Marsden Hospital), Elisabet Fernandez(Institute of Cancer Research), Simon P. Robinson(Institute of Cancer Research), Maria Vinci(Cancer Research UK), Patricia O’Hare(Great Ormond Street Hospital), Jessica K.R. Boult(Institute of Cancer Research)
Cited by 0
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Global warming and recurrent mass bleaching of corals
|Nature|2017|3.4k